Bayview Pharmacy is pleased to present a specialized topical gel formulation of Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2%. This unique compounded formulation is specifically designed to provide targeted relief from a range of musculoskeletal conditions, including muscle spasms, joint pain, and inflammation.

The combination of Diclofenac Sodium and Lidocaine in this formulation offers a potent analgesic effect, effectively reducing pain. The addition of Cyclobenzaprine HCl works to alleviate muscle spasms, further enhancing the therapeutic benefits of this formulation. This makes it a versatile and effective treatment option for various musculoskeletal conditions, helping to alleviate pain and inflammation.

This Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2% topical gel formulation is a semisolid preparation that is dispensed through a pump mechanism. This design facilitates easy and precise application on the skin, allowing for targeted treatment or absorption of the active ingredients. The gel-like consistency ensures a smooth application process, making it user-friendly and convenient for patients.

It is crucial to adhere to the usage instructions provided by your healthcare provider when using this formulation. This will ensure optimal results and minimize the risk of any potential side effects. If you have any queries or concerns about this formulation or its usage, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your healthcare needs.

This compounded formulation of Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2% Topical Gel is a semisolid preparation designed for targeted treatment of musculoskeletal pain, inflammation, and spasm. The gel is dispensed through a pump mechanism, allowing for easy and precise application on the skin. It is crucial to note that this formulation should not be used by individuals with known hypersensitivity to any of the components of the formulation, or by those with a history of gastrointestinal bleeding or ulceration.

When using this formulation, be aware that the simultaneous use of other topical medications, particularly those containing salicylates, may heighten the risk of adverse effects. Similarly, the concurrent use of other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), may increase the risk of gastrointestinal bleeding or ulceration.

Furthermore, this formulation should not be used by individuals with a history of cardiovascular disease, as the combination of lidocaine and cyclobenzaprine may increase the risk of adverse cardiovascular events. This formulation should also be avoided by those with a history of seizure disorders, as the combination of lidocaine and cyclobenzaprine may increase the risk of seizures.

Lastly, it is important to note that this formulation should not be used by pregnant or lactating women, as the safety of this formulation in these populations has not been established. If you have any questions about this formulation or its use, please do not hesitate to reach out for further information.

Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2% Topical Gel is a compounded formulation that combines the therapeutic benefits of three potent medications. This unique blend is designed to alleviate pain and inflammation, making it an effective treatment for a variety of conditions such as muscle and joint pain, inflammation, and spasms.

Diclofenac Sodium, a non-steroidal anti-inflammatory drug (NSAID), works by inhibiting the production of certain chemicals in the body that trigger inflammation and pain. Lidocaine, a local anesthetic, provides pain relief by blocking nerve signals in the area where the gel is applied. Cyclobenzaprine HCl, a muscle relaxant, further enhances the formulation's efficacy by blocking nerve signals that cause muscle spasms and pain.

This topical gel is dispensed through a pump mechanism, which allows for easy and precise application. The gel-like consistency ensures that the active ingredients are absorbed directly into the skin at the site of pain or inflammation. This targeted treatment approach helps to maximize the therapeutic benefits while minimizing potential side effects.

It is crucial to use this medication as directed by your healthcare provider. Typically, the gel should be applied to the affected area two to four times daily, and rubbed in until completely absorbed. After application, hands should be washed thoroughly to avoid accidental contact with the eyes or other mucous membranes. This medication should not be used on broken or irritated skin, and prolonged use beyond 14 days should only be under the guidance of a healthcare professional.

If you have any questions or concerns about using Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2% Topical Gel, it is recommended to consult with your healthcare provider to ensure safe and effective use of this medication.

This compounded formulation of Diclofenac Sodium 10%, Lidocaine 10%, and Cyclobenzaprine HCl 2% is a semisolid topical gel that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin, targeting the treatment area for optimal absorption of the active ingredients. The gel-like consistency ensures a smooth application process.

The formulation is versatile in its application, offering relief for a variety of musculoskeletal conditions. These include myofascial pain syndrome, muscle spasms, and post-traumatic pain. It is also effective in reducing inflammation and pain associated with soft tissue injuries such as sprains and strains.

Furthermore, this formulation can be used to alleviate post-surgical pain and discomfort, as well as the pain associated with post-herpetic neuralgia. This makes it a valuable treatment option for patients who are unable to take oral medications due to gastrointestinal side effects or other contraindications.

However, it is crucial to note that this formulation should not be used on open wounds or on areas of the skin that are broken or irritated. If you have any questions about the use of this formulation, please consult with a healthcare professional.